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S U M M A R Y
The relationship between Streptococcus pneumoniae isolates causing invasive infections in children
admitted to a single center in central Israel was examined by pulsed-ﬁeld gel electrophoresis (PFGE) and
serotyping. Although there was a close correlation between serotype and PFGE clone, the genetic
diversity varied by serotype, with some genotypes comprising multiple serotypes. Additionally, clones C
and D were associated with higher penicillin minimum inhibitory concentrations. Serotyping alone may
be insufﬁcient for epidemiological mapping of pneumococcal isolates in the era of pneumococcal
conjugate polysaccharide vaccines.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-
nc-sa/4.0/).
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A major concern in the era of pneumococcal conjugate
polysaccharide vaccines (7-valent PCV7 and 13-valent PCV13) is
the occurrence of ‘serotype replacement’, which is the increase in
non-vaccine serotypes as causes of asymptomatic carriage and
invasive disease.1 Additionally, through the process of ‘serotype
switching’ the bacteria can acquire a novel capsule type by the
exchange of a sequence at the capsule polysaccharide synthesis
(cps) locus.2 Thus, clones associated with certain serotypes can
persist in the post-vaccine era as mutants expressing non-vaccine
type capsules. The phenomenon of serotype replacement has
already been established for nasopharyngeal colonization after
PCV7 introduction,3 but whether replacement has occurred for
invasive disease and after PCV13 introduction is unclear. The goal
of the present study was to compare clonal distribution with
serotype distribution of pneumococcal isolates causing invasive
infections among children in the Jerusalem area in the pre-vaccine
era. Characterization of the pneumococcal genetic background* Corresponding author. Tel.: +972 2 6666340; fax: +972 2 6666840.
E-mail address: mbarmeir@gmail.com (M. Bar-Meir).
http://dx.doi.org/10.1016/j.ijid.2015.02.023
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-sa/4.0/).may provide the basis for surveillance of replacement disease in
the post-vaccine era.
2. Methods
All children admitted to Shaare Zedek Medical Center with
Streptococcus pneumoniae isolated from a normally sterile body
ﬂuid between the years 2004 and 2006 were identiﬁed. One isolate
per patient was obtained for analysis. Antibiotic susceptibility
testing was performed by agar dilution method on Mueller–Hinton
(Oxoid, Basingstoke, UK) blood agar plates. Serotyping was
performed by capsular reaction testing (Quellung test), using
commercially available antisera (Statens Serum Institute,
Denmark). Chromosomal DNA fragments for pulsed-ﬁeld gel
electrophoresis (PFGE) were generated by ApaI for serotypes
6 and 8 and by SmaI for all other serotypes, and were analyzed as
described previously.4
PFGE genotype was deﬁned as isolates showing >90% identity
in the dendrogram created using Bionumerics ver. 7.1 (Applied
Maths, Belgium) and the UPGMA/Dice coefﬁcients, with a band
position tolerance of 2%, in accordance with published interpretive
criteria.5ciety for Infectious Diseases. This is an open access article under the CC BY-NC-SA
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(SPSS Inc., Chicago, IL, USA). Analysis of variance was used for
comparisons between clones. Simpson’s index of diversity was
used to estimate the bacterial population diversity. This index is a
measure of the probability that two isolates chosen randomly will
belong to the same clone.6
3. Results
During the study period, 96 children had S. pneumoniae isolated
from a normally sterile body ﬂuid. One isolate per patient was
obtained for analysis; seven did not grow from the frozen stocks. Of
the remaining 89 isolates, all were blood isolates, except for two
pleural ﬂuid isolates. The mean age of the patients was 29 months
(range 2 days to 13 years). Overall, 44 (49%) patients had
pneumonia, 34 (38%) had bacteremia without a focus, seven
(8%) had meningitis, and four patients had bacteremia with
another focus of infection (three cellulitis, one peritonitis). One
patient died of pneumococcal sepsis.
Eighty-two (92%) isolates belonged to PCV13. The non-PCV13
serotypes were 12F (n = 4) and one each of serotypes 8, 6C, and
15B. The 89 isolates were represented by 38 different PFGE
genotypes, with 67% belonging to nine major genotypes
(Table 1). All major genotypes comprised one serogroup each.
Serotypes 18C, 19A, and 19F were represented by three to seven
different clones. Twenty-nine genotypes contained only one
isolate each of serotypes 1, 3, 4, 5, 6B, 6C, 8, 9 V, 14, 15B, 18B, 18C,
19A, 19F, and 23F. The genetic diversity of the isolates was 88%
when serotype distribution was considered and 92% when the
distribution of major PFGE genotypes was considered (p = not
signiﬁcant).
The penicillin minimum inhibitory concentration (MIC) for all
isolates ranged from 0.002 mg/l to 1 mg/l. Isolates of PFGE groups
C and D (corresponding with serotypes 14 and 23F) exhibited
higher median penicillin MICs with a wider distribution compared
to the other clones (p = 0.0001). Erythromycin resistance (MIC
1 mg/l) was frequent among isolates of PFGE types F and G,
corresponding with serotypes 6A and 6B. PFGE groups A and C
were associated with pneumonia (odds ratio (OR) 3, 95%
conﬁdence interval (CI) 0.8–12 and OR 1.5, 95% CI 0.3–7.8,
respectively) and PFGE group B was associated with bacteremia
(OR 3.1, 95% CI 0.9–11), but none of these associations were
statistically signiﬁcant.Table 1
Correlation between major pneumococcal genotypes and serotypes
Major
PFGE
clone
Serotype Total
1 5 14 23F 12F 6A 6B 19F 19A 18C Other
A 17 17
B 16 16
C 9 9
D 3 3
E 4 4
F 4 4
G 2 2
H 2 2
I 3 3
Othera 1 1 3 3 0 0 2 2 7 3 7 29
Total 21 17 12 6 4 4 4 4 7 3 7 89
PFGE, pulsed-ﬁeld gel electrophoresis.
a ‘Other’ represents 29 separate PFGE clones. For example, serotype 19A is
represented by seven different PFGE genotypes and 18C by three different PFGE
genotypes. Serotype 14 is represented by PFGE genotype C along with three isolates
with different genotypes. For serotype 23F, three isolates belong to PFGE genotype
D and three belong to three different genotypes.4. Discussion
This study demonstrated a close correlation between serotype
and PFGE genotype, although genetic diversity varied by serotype.
For example, serotypes 6A and 12F were found to be mostly clonal,
while serotypes 18C and 19A had high genetic diversity and were
represented by multiple clones.
A similar phenomenon was found in a recent study from
southern Israel,7 where serotype 5 was represented by only one
clone and serotype 15B/C by 12 minor clones. Since clonal
distribution in that study differed between acute otitis media and
invasive infections, it was suggested that, in addition to the
capsule, the genetic background of the bacteria may also play a role
in dictating virulence. Another study that investigated the
persistence of ﬂuoroquinolone-resistant S. pneumoniae in a long-
term care facility, demonstrated how a capsular switch along with
multiple antimicrobial resistance mutations occurred within a
single clone.8 Taken together, these data highlight the need to
continue long-term genetic cloning for surveillance of replacement
disease in the era of pneumococcal conjugate vaccines.
Additionally, we detected a correlation between PFGE clone and
penicillin MIC, with clones C and D presenting higher penicillin
MICs. This is consistent with studies from around the world, which
have demonstrated differences in resistance proﬁle among strains
of the same genetic clone.9,10 Horizontal transfer of penicillin
resistance genes between pneumococcal clones or from viridans
streptococci has been described, with some clones being more
‘promiscuous’, e.g., more likely to transfer multiple genes to other
clones.11
Clones C and D corresponded with serotypes 14 and 23F, and
both belong to the so-called ‘pediatric serotypes’, which tend to be
more antibiotic-resistant.12We did not ﬁnd isolates with dual non-
susceptibility to penicillin and macrolides. This is in agreement
with the most recent European Antimicrobial Resistance Surveil-
lance System report, which noted dual non-susceptibility in
Europe to be below 5%.13
In summary, the data presented here suggest that serotyping
alone would be insufﬁcient for surveillance in the era of the
conjugated vaccines, and clonal distribution should be monitored
to detect replacement disease.
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